Detalles de la búsqueda
1.
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
Br J Cancer
; 126(12): 1715-1724, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35194193
2.
Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
Ann Surg Oncol
; 29(2): 1061-1070, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34647202
3.
Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status.
Arch Gynecol Obstet
; 303(1): 217-230, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32929618
4.
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
BMC Cancer
; 18(1): 141, 2018 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29409452
5.
CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
Tumour Biol
; 37(10): 13769-13775, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27481512
6.
Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
Oncology
; 90(4): 232-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26937631
7.
Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
BMC Cancer
; 16: 401, 2016 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27387743
8.
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
Arch Gynecol Obstet
; 293(2): 271-81, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26354331
9.
The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.
Breast Cancer Res
; 17: 129, 2015 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26385214
10.
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial.
Cancers (Basel)
; 14(16)2022 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36010945
11.
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.
J Natl Cancer Inst
; 111(4): 380-387, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30312434
12.
Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study.
Breast
; 44: 81-89, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30690254
13.
Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
Oncol Res Treat
; 41(3): 93-98, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29490302
14.
EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients.
Oncotarget
; 9(86): 35705-35716, 2018 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30479699
15.
LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
Mol Oncol
; 11(11): 1508-1526, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28700115
16.
Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A study.
Breast
; 35: 130-135, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28732324
17.
Discordance in Human Epidermal Growth Factor Receptor 2 (HER2) Phenotype Between Primary Tumor and Circulating Tumor Cells in Women With HER2-Negative Metastatic Breast Cancer.
JCO Precis Oncol
; 1: 1-12, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172510
18.
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Clin Breast Cancer
; 17(4): 279-285, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28190761
19.
Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells.
Anticancer Res
; 36(6): 3123-30, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27272837
20.
Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
Anticancer Res
; 36(9): 4771-6, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27630326